APPROVED USE UZEDY ® (risperidone) extended-release injectable suspension is a prescription medicine used in adults. for the treatment of schizophrenia for the maintenance treatment of bipolar I …

Uzedy is an injection that contains the antipsychotic medicine risperidone. Uzedy helps control psychotic symptoms of schizophrenia, such as hallucinations and delusions.

Oct 14, 2025 · Uzedy is a long-acting injectable form of risperidone that is used to treat adults with schizophrenia or bipolar I disorder.

INDICATIONS AND USAGE UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated in adults for the treatment of schizophrenia and as monotherapy or as …

If you take Perseris® (risperidone long-acting injection), it is not recommended to take oral risperidone after the first injection. Antipsychotic treatment is generally needed lifelong for persons with …

Nov 16, 2023 · Uzedy (Risperidone) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.

Compared to placebo, risperidone extended-release injection (Uzedy®) once monthly and once every two months have been shown to significantly prolong time to relapse in patients with schizophrenia.

Jan 24, 2025 · UZEDY is indicated for the treatment of schizophrenia in adults. 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage For patients who have never taken risperidone, …

Uzedy, an extended-release, subcutaneous (SC) formulation of the second-generation antipsychotic drug risperidone, was approved by the FDA in 2023 for treatment of schizophrenia in adults. It has …

Indication(s) Under Review in This Document1 • Risperidone SC 1-2 month (UZEDY) is indicated for the treatment of schizophrenia in adults.